SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
[November 08, 2018]

T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum


LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum. The conference is being held on November 15 at the Westin Grand Central in New York.

Mr. McDonough is scheduled to present on Thursday, November 15, 2018 at 11:00 a.m. ET. Mr. McDonough and John Sprague, chief financial officer, will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay, ad may be accessed by visiting the Investors/Events & Presentations section of the Company’s website at www.t2biosystems.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 90 days following the presentation.



About T2 Biosystems:
T2 Biosystems, a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, and T2Bacteria® Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease. For more information, please visit www.t2biosystems.com.

Media Contact:
Gina Kent, Vault Communications
gkent@vaultcommunications.com
610-455-2763


Investor Contact:
Zack Kubow, W2O Group
zkubow@w2ogroup.com
415-946-1053 

T2Biosystems_Logo.jpg


[ Back To TMCnet.com's Homepage ]







Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy